caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1912151150

Miranda HardeeMD

PRACTICEUROLOGY AUSTIN, PLLCSee all providers at this practice →
UrologyAustin, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,207
Unique beneficiaries
—
Total services
13,336
Distinct HCPCS
22
Medicare payment
$214K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 656 Urology providers in TX — top quintile (cohort median 2,730).
REFERRAL NETWORK

Where Miranda Hardee's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
278795
Melody Denson
Urology · Austin, TX
2454
Loren Jones
Urology · Austin, TX
2038
Danielle Manes
Physician Assistant · Austin, TX
1938
Bryan Kansas
Urology · Austin, TX
1836
ASCENSION SETON1738
Ara/St. David's Imaging, Lp
Independent Diagnostic Testing Facility (IDTF) · Austin, TX
1433
Stephen Hardeman
Urology · Austin, TX
1218
ASCENSION SETON1230
Eric Giesler
Urology · Austin, TX
1119
WESTLAKE SURGICAL, L.P.1123
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
2,792
Beneficiaries
—
Total drug cost
$488K
Distinct drugs
34
Brand share
41.9%
Top prescribed drugs
Estradiol358 claims
Nitrofurantoin Monohyd/M-Cryst301 claims
Cephalexin299 claims
Vibegron230 claims
Mirabegron185 claims
QUALITY · MIPS · 2024
Final MIPS score
93.2
Quality
13.4
Cost
72.6
Improvement activities
40.0
Promoting interop.
92.0
Payment adjustment
0.77%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
75
By payment type
Food and Beverage$1K